A novel adipokine WISP1 attenuates lipopolysaccharide-induced cell injury in 3T3-L1 adipocytes by regulating the PI3K/Akt pathway
- 14 April 2022
- journal article
- research article
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 16 (2) , 122-129
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cellsStem Cell Research & Therapy, 2015
- New Insights for Oxidative Stress and Diabetes MellitusOxidative Medicine and Cellular Longevity, 2015
- Endotoxemia of Metabolic Syndrome: A Pivotal Mediator of Meta-InflammationMetabolic Syndrome and Related Disorders, 2014
- WISP1 Is a Novel Adipokine Linked to Inflammation in ObesityDiabetes, 2014
- Adipocyte Inflammation Is Essential for Healthy Adipose Tissue Expansion and RemodelingCell Metabolism, 2014
- Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulinNature Immunology, 2014
- The gut microbiota, obesity and insulin resistanceMolecular Aspects of Medicine, 2013
- WISP1 Neuroprotection Requires FoxO3a Post-Translational Modulation with Autoregulatory Control of SIRT1Current Neurovascular Research, 2013
- Targeting adipocyte apoptosis: A novel strategy for obesity therapyBiochemical and Biophysical Research Communications, 2012
- WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte deathCellular Signalling, 2010